한글목차

식물 유래 백신 시장 규모는 최근 급성장하고 있습니다. 2025년 18억 1,000만 달러에서 2026년에는 19억 9,000만 달러에 이르고, CAGR 10.2%의 성장이 전망되고 있습니다. 지금까지의 성장 요인으로는 개발도상국의 냉장 유통 인프라 부족, 기존 백신 제조의 높은 비용, 인수공통전염병 증가 추세, 식물분자농업의 학술적 연구 선행, 대체 생물학적 제제에 대한 정부 지원 등을 꼽을 수 있습니다.

식물 유래 백신 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 30억 6,000만 달러에 이르고, CAGR은 11.3%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 확장 가능한 백신 플랫폼에 대한 수요 증가, 팬데믹 대응 프로그램 확대, 식물 생명공학 스타트업에 대한 투자 증가, 비용 효율적인 동물용 백신에 대한 수요, 새로운 백신 플랫폼에 대한 규제 개선 등을 꼽을 수 있습니다. 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 식물의 재조합 항원 발현 확대, 수의학 백신용 식물 기반 플랫폼 채택 증가, 경구 및 식용 백신 개발에 대한 관심 증가, 대체 백신 플랫폼에 대한 공공 및 민간 자금 증가, 다운스트림 공정 처리 및 정제 기술 발전 등을 들 수 있습니다.

감염성 질환의 높은 유병률은 향후 몇 년 동안 식물 유래 백신 시장의 성장을 견인할 것으로 예측됩니다. 감염병은 세균, 바이러스, 기생충 등 병원성 미생물에 의해 발생하는 질병으로, 직간접적인 감염 경로를 통해 전파되어 전 세계인의 건강에 큰 위험을 초래하는 질병입니다. 감염 사례 증가는 국제 이동 증가, 도시 과밀화, 특정 집단의 면역력 저하 등의 요인에 의해 영향을 받고 있습니다. 식물 유래 백신은 이러한 증가하는 건강 문제에 효과적으로 대응할 수 있도록 신속한 규모 확대와 적응이 가능한 혁신적인 플랫폼을 제공합니다. 예를 들어, 미국 질병예방통제센터(CDC)에 따르면, 2024년 3월 기준 결핵 환자 수는 2022년 8,320건에서 2023년 9,615건으로 1,295건 증가하였습니다. 따라서 감염성 질환의 높은 유병률은 식물 유래 백신 시장의 확대에 기여하고 있습니다.

식물 유래 백신 시장에서 사업을 전개하고 있는 주요 기업들은 임상 단계의 생산 능력 확대와 차세대 바이러스 유사 입자(VLP) 기반 백신의 개발 가속화를 위해 전략적 제조 제휴를 추진하고 있습니다. 이러한 제조 파트너십은 다운스트림 공정의 효율화, 우수의약품 제조 및 품질관리기준(GMP) 준수, 초기 연구단계에서 임상개발로의 원활한 전환을 지원하기 위한 목적으로 설계되었습니다. 예를 들어, 2024년 12월, 혁신적인 백신의 식물 유래 바이오 제조에 주력하는 캐나다 기업 Aramis Biotechnologies Inc.는 cGMP를 준수하는 복잡한 생물학적 제제를 전문으로 하는 캐나다의 위탁 개발 및 제조 기관인 Biodextris Inc. II상 임상시험을 지원하였습니다. 이번 제휴를 통해 바이오덱스트리스는 식물 유래 VLP 백신 후보물질의 정제, 제형화, 충진 및 마무리 공정을 담당하여 신속한 스케일업, 생산 품질 향상, 고급 임상 평가를 위한 준비 태세를 강화할 수 있게 되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Plant-based vaccines are recombinant vaccines in which antigens targeting specific infections are expressed in selected plant species. These vaccines have the potential to effectively prevent or treat a wide range of human and animal diseases.

The main types of plant-based vaccines include bacterial vaccines, viral vaccines, parasite vaccines, and others. Bacterial vaccines are preparations made from inactivated or weakened bacteria that are used as active immunizing agents. These vaccines are produced using various plant sources such as tobacco plants, maize, potatoes, and others, and are applied in areas including influenza, Zika virus, Ebola virus, poultry diseases, and other applications.

Tariffs have influenced the plant-based vaccines market by increasing costs for imported bioprocessing equipment, reagents, and genetically engineered plant materials used in recombinant vaccine production. These impacts are most evident across viral and bacterial vaccine segments and in regions reliant on cross-border supply chains such as North America, Europe, and parts of Asia-Pacific. Higher tariffs have led manufacturers to reassess sourcing strategies and delay capacity expansion in some cases. However, tariffs have also encouraged localized manufacturing, domestic cultivation of plant sources, and regional R&D investments, supporting long-term supply chain resilience and innovation.

The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides plant-based vaccines market statistics, including plant-based vaccines industry global market size, regional shares, competitors with a plant-based vaccines market share, detailed plant-based vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. This plant-based vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to limited cold chain infrastructure in developing regions, high cost of conventional vaccine production, increasing prevalence of zoonotic diseases, early academic research in plant molecular farming, government support for alternative biologics.

The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to rising demand for scalable vaccine platforms, growth in pandemic preparedness programs, increasing investment in plant biotechnology startups, demand for cost-effective veterinary vaccines, regulatory progress for novel vaccine platforms. Major trends in the forecast period include expansion of recombinant antigen expression in plants, rising adoption of plant-based platforms for veterinary vaccines, increased focus on oral and edible vaccine development, growing public and private funding for alternative vaccine platforms, advancements in downstream processing and purification technologies.

The high prevalence of infectious diseases is anticipated to drive the growth of the plant-based vaccines market in the coming years. Infectious diseases are conditions caused by pathogenic microorganisms such as bacteria, viruses, or parasites, which can spread through direct or indirect transmission and pose substantial global health risks. The rise in infectious disease cases is influenced by factors including increased global travel, urban overcrowding, and reduced immunity in certain population groups. Plant-based vaccines provide innovative platforms that can be rapidly scaled and adapted to respond effectively to these growing health challenges. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, reflecting a rise of 1,295 cases. Therefore, the high prevalence of infectious diseases is contributing to the expansion of the plant-based vaccines market.

Leading companies operating in the plant-based vaccines market are pursuing strategic manufacturing collaborations to expand clinical-stage production capacity and accelerate the development of next-generation virus-like particle (VLP)-based vaccines. These manufacturing partnerships are designed to improve downstream processing efficiency, ensure compliance with good manufacturing practices (GMP), and support a smooth transition from early research stages to clinical development. For example, in December 2024, Aramis Biotechnologies Inc., a Canada-based company focused on plant-based biomanufacturing of innovative vaccines, entered into a partnership with Biodextris Inc., a Canada-based contract development and manufacturing organization specializing in cGMP complex biologics, to support Phase 1 and Phase 2 clinical trials. Under this collaboration, Biodextris will handle purification, formulation, and fill-finish operations for plant-derived VLP vaccine candidates, enabling faster scale-up, improved production quality, and enhanced readiness for advanced clinical evaluation.

In December 2023, Aramis Biotechnologies, a Canada-based biotechnology company, acquired key assets from Medicago for an undisclosed amount. Through this acquisition, Aramis seeks to strengthen its position in the plant-based vaccines market by utilizing Medicago's virus-like particle platform to develop next-generation influenza vaccines and therapeutics. The transaction also preserves high-speed domestic manufacturing capabilities, supporting sustainable biomanufacturing and enhanced pandemic preparedness. Medicago is a Canada-based biotechnology company that develops vaccines using plant-based technology.

Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plant-based vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plant-based vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Bacterial Vaccines; Viral Vaccines; Parasite Vaccines; Other Vaccine Types
• 2) By Source: Tobacco Plant; Maize; Potato; Other Sources
• 3) By Application: Influenza; Zika Virus; Ebola Virus; Poultry Disease; Other Applications
• Subsegments:
• 1) By Bacterial Vaccines: Recombinant Bacterial Vaccines; Conjugate Bacterial Vaccines; DNA-Based Bacterial Vaccines
• 2) By Viral Vaccines: Inactivated Viral Vaccines; Live Attenuated Viral Vaccines; Subunit Viral Vaccines
• 3) By Parasite Vaccines: Recombinant Parasite Vaccines; DNA-Based Parasite Vaccines
• 4) By Other Vaccine Types: Fungal Vaccines; Multivalent Vaccines; Toxin-Based Vaccines
• Companies Mentioned: British American Tobacco PLC; Medicago Inc.; Creative Biolabs Inc.; Fraunhofer USA Inc.; Biodextris Inc.; Avesthagen Limited; Calyxt Inc.; Mapp Biopharmaceutical Inc.; Kentucky BioProcessing Inc.; Planet Biotechnology Inc.; Icon Genetics GmbH; PlantForm Corporation; LenioBio GmbH; iBio Inc.; Lumen Bioscience Inc.; Baiya Phytopharm Co. Ltd.; Greenovation Biotech GmbH; Pevion Biotech AG; Zyus Life Sciences Inc.; Agenus Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Plant-Based Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Plant-Based Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Plant-Based Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Plant-Based Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Expansion Of Recombinant Antigen Expression In Plants
  • 4.2.2 Rising Adoption Of Plant-Based Platforms For Veterinary Vaccines
  • 4.2.3 Increased Focus On Oral And Edible Vaccine Development
  • 4.2.4 Growing Public And Private Funding For Alternative Vaccine Platforms
  • 4.2.5 Advancements In Downstream Processing And Purification Technologies

5. Plant-Based Vaccines Market Analysis Of End Use Industries

• 5.1 Pharmaceutical And Biotechnology Companies
• 5.2 Veterinary Healthcare Companies
• 5.3 Research And Academic Institutes
• 5.4 Government And Public Health Organizations
• 5.5 Contract Research And Manufacturing Organizations

6. Plant-Based Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plant-Based Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Plant-Based Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Plant-Based Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Plant-Based Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Plant-Based Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plant-Based Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plant-Based Vaccines Market Segmentation

• 9.1. Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
• 9.2. Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tobacco Plant, Maize, Potato, Other Sources
• 9.3. Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications
• 9.4. Global Plant-Based Vaccines Market, Sub-Segmentation Of Bacterial Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
• 9.5. Global Plant-Based Vaccines Market, Sub-Segmentation Of Viral Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
• 9.6. Global Plant-Based Vaccines Market, Sub-Segmentation Of Parasite Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
• 9.7. Global Plant-Based Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

10. Plant-Based Vaccines Market Regional And Country Analysis

• 10.1. Global Plant-Based Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Plant-Based Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plant-Based Vaccines Market

• 11.1. Asia-Pacific Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plant-Based Vaccines Market

• 12.1. China Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plant-Based Vaccines Market

• 13.1. India Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plant-Based Vaccines Market

• 14.1. Japan Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plant-Based Vaccines Market

• 15.1. Australia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plant-Based Vaccines Market

• 16.1. Indonesia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plant-Based Vaccines Market

• 17.1. South Korea Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plant-Based Vaccines Market

• 18.1. Taiwan Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plant-Based Vaccines Market

• 19.1. South East Asia Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plant-Based Vaccines Market

• 20.1. Western Europe Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plant-Based Vaccines Market

• 21.1. UK Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plant-Based Vaccines Market

• 22.1. Germany Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plant-Based Vaccines Market

• 23.1. France Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plant-Based Vaccines Market

• 24.1. Italy Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plant-Based Vaccines Market

• 25.1. Spain Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plant-Based Vaccines Market

• 26.1. Eastern Europe Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plant-Based Vaccines Market

• 27.1. Russia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plant-Based Vaccines Market

• 28.1. North America Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plant-Based Vaccines Market

• 29.1. USA Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plant-Based Vaccines Market

• 30.1. Canada Plant-Based Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plant-Based Vaccines Market

• 31.1. South America Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plant-Based Vaccines Market

• 32.1. Brazil Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plant-Based Vaccines Market

• 33.1. Middle East Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plant-Based Vaccines Market

• 34.1. Africa Plant-Based Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Plant-Based Vaccines Market, Segmentation By Vaccine Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plant-Based Vaccines Market Regulatory and Investment Landscape

36. Plant-Based Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Plant-Based Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Plant-Based Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Plant-Based Vaccines Market Company Profiles
  • 36.3.1. British American Tobacco PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medicago Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Creative Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Fraunhofer USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Biodextris Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Plant-Based Vaccines Market Other Major And Innovative Companies

• Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

38. Global Plant-Based Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

40. Plant-Based Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Plant-Based Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Plant-Based Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Plant-Based Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer